Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma

D K C Lee, C M Jackson, G P Currie, W J Cockburn, B J Lipworth

Research output: Contribution to journalArticlepeer-review

Abstract

Aims Inhalers combining long acting beta(2)-adrenoceptor agonists (LABA) and corticosteroids (ICS) are indicated at Step 3 of current asthma guidelines. We evaluated the relative effects of LABA + ICS combination vs ICS alone on pulmonary function, bronchoprotection, acute salbutamol recovery following methacholine bronchial challenge, and surrogate inflammatory markers in patients with moderate persistent asthma.

Methods Twenty-nine patients with mean FEV1 (+/- SEM) of 78 +/- 3% predicted completed a randomized, double-blind, double-dummy, cross-over study. Patients received either 4 weeks of budesonide 400 mug + formoterol 12 mug (BUD + FM) combination twice daily followed by 1 week of BUD 400 mug alone twice daily, or 4 weeks of fluticasone propionate 250 mug + salmeterol 50 mug (FP + SM) combination twice daily followed by 1 week of FP 250 mug alone twice daily. Measurements were made at baseline and following each randomized treatment.

Results FEV1 increase from pretreatment baseline as mean (+/- SEM) % predicted was significantly higher (P < 0.05) for BUD + FM (8 +/- 1%) vs BUD (2 +/- 1%), and for FP + SM (8 +/- 1%) vs FP (2 +/- 1%). The fall in FEV1 following methacholine challenge as percentage change from prechallenge baseline FEV1 was not significantly different in all four groups; BUD + FM (22 +/- 1%), BUD (24 +/- 1%), FP + SM (23 +/- 1%) and FP (23 +/- 1%). Salbutamol recovery over 30 min following methacholine challenge as area under curve (AUC %.min) was significantly blunted (P < 0.05) with BUD + FM (486.7 +/- 35.5) vs BUD (281.1 +/- 52.8), and with FP + SM (553.1 +/- 34.1) vs FP (368.3 +/- 46.7). There were no significant differences between respective combination inhalers or between respective ICS alone. Decreases in exhaled nitric oxide (NO) and serum eosinophilic cationic protein (ECP) from baseline were not significantly different between treatments.

Conlusions Combination inhalers improve pulmonary function without potentiating anti-inflammatory effects on exhaled NO and serum ECP as compared with ICS alone, but delay acute salbutamol recovery after bronchoconstriction.

Original languageEnglish
Pages (from-to)494-500
Number of pages7
JournalBritish Journal of Clinical Pharmacology
Volume56
Issue number5
DOIs
Publication statusPublished - Nov 2003

Fingerprint

Dive into the research topics of 'Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma'. Together they form a unique fingerprint.

Cite this